FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
Using machine learning to predict how people diagnosed with major depressive disorder respond to treatment
Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Largest study on the genetics of bipolar disorder to date gives new insights into the underlying biology
Bipolar disorder is a complex psychiatric disorder, characterized by fluctuations between episodes of (hypo)mania and ...
January is peak time for seasonal affective disorder: What it is and how to cope, according to an expert
Many Canadians struggle with SAD, a real form of depression that can make navigating the winter months extremely difficult.
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
NOLA.com2d
Is Alzheimer's patient's depression due to seasonal affective disorder? Here are some signs
Seasonal affective disorder (SAD) is a type of recurrent depressive periods that occur during the same season each year. SAD ...
Healio12h
FDA approves Spravato as monotherapy for adults with major depressive disorder
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...
Science Daily1h
How your brain learns from rewards might hold the key to treating depression
Using computational models, the researchers studied how the brain's reward-learning system functions in those with depression, especially among individuals experiencing anhedonia, the inability to ...
Indiana Gazette12h
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...